Terms: = Ovarian cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Prognosis
29 results:
1. Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer.
Bartl T; Alberts A; Papadopoulos SC; Wolf A; Muellauer L; Hofstetter G; Grimm C; Cacsire Castillo-Tong D
Int J Gynecol Cancer; 2023 Sep; 33(9):1419-1426. PubMed ID: 37094966
[TBL] [Abstract] [Full Text] [Related]
2. VISTA+/CD8+ status correlates with favorable prognosis in Epithelial ovarian cancer.
Jlassi A; Manai M; Morjen M; Sahraoui G; Elasmi Allal M; ELBini-Dhouib I; Naija L; Charfi L; Rejaibi R; Ben Ahmed M; Marrakchi N; Srairi-Abid N; Mezlini A; Manai M; Mrad K; Doghri R
PLoS One; 2023; 18(3):e0278849. PubMed ID: 36952478
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma.
Marchenko S; Piwonski I; Hoffmann I; Sinn BV; Kunze CA; Monjé N; Pohl J; Kulbe H; Schmitt WD; Darb-Esfahani S; Braicu EI; von Brünneck AC; Sehouli J; Denkert C; Horst D; Jöhrens K; Taube ET
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2523-2536. PubMed ID: 35763108
[TBL] [Abstract] [Full Text] [Related]
4. The worsening impact of programmed cell death ligand 1 in ovarian clear cell carcinomas.
Matsuura H; Miyamoto M; Hada T; Ishibashi H; Iwahashi H; Kakimoto S; Suzuki R; Ito T; Suminokura J; Tsuda H; Takano M
Arch Gynecol Obstet; 2022 Dec; 306(6):2133-2142. PubMed ID: 35507079
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of
Jiang S; Yang Y; Zhang Y; Ye Q; Song J; Zheng M; Li X
Dis Markers; 2022; 2022():9719671. PubMed ID: 35186171
[TBL] [Abstract] [Full Text] [Related]
6. Clinical significance of CD8-positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high-grade serous carcinoma.
Iwahashi H; Miyamoto M; Ito T; Suminokura J; Hada T; Ishibashi H; Kakimoto S; Matsuura H; Suzuki R; Minabe S; Matsukuma S; Tsuda H; Takano M
Cancer Med; 2022 May; 11(10):2085-2095. PubMed ID: 35137571
[TBL] [Abstract] [Full Text] [Related]
7. Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in ovarian High-Grade Serous Carcinoma.
Spiliopoulou P; Spear S; Mirza H; Garner I; McGarry L; Grundland-Freile F; Cheng Z; Ennis DP; Iyer N; McNamara S; Natoli M; Mason S; Blyth K; Adams PD; Roxburgh P; Fuchter MJ; Brown B; McNeish IA
Mol Cancer Ther; 2022 Apr; 21(4):522-534. PubMed ID: 35131874
[TBL] [Abstract] [Full Text] [Related]
8. Application of Immunoprofiling Using Multiplexed Immunofluorescence Staining Identifies the prognosis of Patients with High-Grade Serous ovarian cancer.
Lee SW; Lee HY; Kang SW; Kim MJ; Lee YJ; Sung CO; Kim YM
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502561
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of Twenty Genes in prognosis of Patients with ovarian cancer Using Four Different Clustering Methods.
Pourahmad S; Foroozani S; Nourelahi M; Hosseini A; Razmkhah M
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1781-1787. PubMed ID: 34181334
[TBL] [Abstract] [Full Text] [Related]
10. Clinical Significance of Tumor Infiltrating Lymphocytes in Association with Hormone Receptor Expression Patterns in Epithelial ovarian cancer.
Han GH; Hwang I; Cho H; Ylaya K; Choi JA; Kwon H; Chung JY; Hewitt SM; Kim JH
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071938
[TBL] [Abstract] [Full Text] [Related]
11. Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression.
Jiang R; Zhang H; Zhou J; Wang J; Xu Y; Zhang H; Gu Y; Fu F; Shen Y; Zhang G; Feng L; Zhang X; Chen Y; Shen F
Cell Death Dis; 2021 Feb; 12(2):145. PubMed ID: 33542185
[TBL] [Abstract] [Full Text] [Related]
12. Molecular phenotype of high-grade endometrioid carcinoma of the endometrium.
Buchynska LG; Glushchenko NM; Nesina IP; Brieieva OV; Iurchenko NP
Exp Oncol; 2020 Dec; 42(4):300-305. PubMed ID: 33355863
[TBL] [Abstract] [Full Text] [Related]
13. The investigation of T-cell receptor subtypes in ovarian cancer: effects on survival and prognostic factors.
Özkan S; Selvi Gunel N; Aygünes D; Akman L; Yildirim N; Teti K Vardarli A; Özsaran A; Terek C
J Obstet Gynaecol; 2021 Aug; 41(6):951-955. PubMed ID: 33228419
[TBL] [Abstract] [Full Text] [Related]
14. A novel method for efficient generation of antigen-specific effector T-cells using dendritic cells transduced with recombinant adeno-associated virus and p38 kinase blockade.
Mirandola L; Chiriva-Internati M; Bresalier R; Piccotti L; Grizzi F; Marincola FM
J Transl Med; 2019 Dec; 17(1):424. PubMed ID: 31878933
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of the treg cell population in the peripheral blood of ovarian cancer patients in relation to the long-term outcomes.
Dutsch-Wicherek MM; Szubert S; Dziobek K; Wisniewski M; Lukaszewska E; Wicherek L; Jozwicki W; Rokita W; Koper K
Ginekol Pol; 2019; 90(4):179-184. PubMed ID: 31059109
[TBL] [Abstract] [Full Text] [Related]
16. Follicular regulatory T cells infiltrated the ovarian carcinoma and resulted in CD8 T cell dysfunction dependent on IL-10 pathway.
Li L; Ma Y; Xu Y
Int Immunopharmacol; 2019 Mar; 68():81-87. PubMed ID: 30616170
[TBL] [Abstract] [Full Text] [Related]
17. miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers.
Givel AM; Kieffer Y; Scholer-Dahirel A; Sirven P; Cardon M; Pelon F; Magagna I; Gentric G; Costa A; Bonneau C; Mieulet V; Vincent-Salomon A; Mechta-Grigoriou F
Nat Commun; 2018 Mar; 9(1):1056. PubMed ID: 29535360
[TBL] [Abstract] [Full Text] [Related]
18. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA
Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043
[TBL] [Abstract] [Full Text] [Related]
19. Do tumor-infiltrating lymphocytes really indicate favorable prognosis in epithelial ovarian cancer?
Yildirim N; Akman L; Acar K; Demir S; Ozkan S; Alan N; Zekioglu O; Terek MC; Ozdemir N; Ozsaran A
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():55-61. PubMed ID: 28601728
[TBL] [Abstract] [Full Text] [Related]
20. The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.
Li J; Wang J; Chen R; Bai Y; Lu X
Oncotarget; 2017 Feb; 8(9):15621-15631. PubMed ID: 28152503
[TBL] [Abstract] [Full Text] [Related]
[Next]
